James Andrew Eastham
#116,184
Most Influential Person Now
James Andrew Eastham's AcademicInfluence.com Rankings
James Andrew Easthamphilosophy Degrees
Philosophy
#5053
World Rank
#7766
Historical Rank
Logic
#2394
World Rank
#3379
Historical Rank
James Andrew Easthambiology Degrees
Biology
#6742
World Rank
#9525
Historical Rank
Computational Biology
#117
World Rank
#117
Historical Rank
Download Badge
Philosophy Biology
James Andrew Eastham's Degrees
- PhD Biomedical Sciences University of California, San Francisco
- Bachelors Biology Stanford University
Similar Degrees You Can Earn
Why Is James Andrew Eastham Influential?
(Suggest an Edit or Addition)James Andrew Eastham's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Integrative genomic profiling of human prostate cancer. (2010) (3312)
- A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. (1998) (1269)
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score. (2016) (1075)
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer (2014) (1074)
- Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. (2019) (1026)
- NCCN clinical practice guidelines in oncology: prostate cancer. (2010) (971)
- Prostate cancer. Clinical practice guidelines in oncology. (2007) (839)
- Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. (2006) (675)
- Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. (2003) (666)
- Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. (2012) (628)
- Predicting 15-year prostate cancer specific mortality after radical prostatectomy. (2011) (600)
- Prostate Cancer, Version 1.2016. (2016) (586)
- Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. (2005) (574)
- Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). (2005) (534)
- Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. (2006) (473)
- Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. (2009) (430)
- A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. (2010) (403)
- Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. (2011) (401)
- Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. (2012) (393)
- A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer. (2003) (393)
- The surgical learning curve for prostate cancer control after radical prostatectomy. (2007) (380)
- Risk factors for urinary incontinence after radical prostatectomy. (1996) (368)
- Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. (2003) (364)
- Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines. (2012) (358)
- Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. (2003) (337)
- Androgen receptor mutations in prostate cancer. (2000) (334)
- Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. (2005) (331)
- The role of SPINK1 in ETS rearrangement-negative prostate cancers. (2008) (327)
- Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores (2015) (322)
- Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. (2014) (316)
- Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. (2010) (299)
- Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. (2008) (288)
- Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. (2012) (277)
- Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology (2014) (277)
- Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. (2014) (271)
- Advances in magnetic resonance imaging: how they are changing the management of prostate cancer. (2011) (270)
- Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. (2005) (270)
- Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. (2007) (269)
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer (2010) (269)
- TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. (2009) (267)
- In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. (1995) (266)
- Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. (2012) (266)
- Prostate cancer, version 2.2014. (2014) (252)
- Variation of serum prostate-specific antigen levels: an evaluation of year-to-year fluctuations. (2003) (241)
- Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? (1994) (236)
- Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. (2009) (233)
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome (2007) (228)
- Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. (2004) (226)
- Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. (2012) (225)
- Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. (2012) (225)
- Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods. (2007) (221)
- A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. (2012) (219)
- Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer. (2006) (216)
- International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy. (2002) (205)
- NCCN Guidelines Insights: Prostate Cancer, Version 1.2021. (2021) (201)
- Prognostic significance of location of positive margins in radical prostatectomy specimens. (2007) (200)
- The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer. (2006) (199)
- Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. (2014) (192)
- Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. (2008) (190)
- Role of prostate specific antigen and immediate confirmatory biopsy in predicting progression during active surveillance for low risk prostate cancer. (2011) (184)
- Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. (2011) (182)
- Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram. (2008) (178)
- Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. (2009) (178)
- Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005. (2008) (169)
- Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. (2005) (166)
- Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. (2014) (165)
- Comprehensive standardized report of complications of retropubic and laparoscopic radical prostatectomy. (2010) (165)
- Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. (1996) (163)
- Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer. (1999) (163)
- Testosterone as a predictor of pathological stage in clinically localized prostate cancer. (2005) (149)
- Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading. (2006) (148)
- Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. (2005) (145)
- Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50 (2011) (144)
- Long-term outcome among men with conservatively treated localised prostate cancer (2006) (143)
- High‐intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure (2009) (143)
- B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. (2008) (142)
- Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer (2008) (138)
- Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. (2008) (137)
- Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. (1995) (135)
- Impact of prior prostate radiation on complications after radical prostatectomy. (2010) (135)
- Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival. (2009) (135)
- Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. (2006) (133)
- Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review. (2012) (132)
- Treatment of chronic prostatitis lowers serum prostate specific antigen. (2002) (132)
- Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study (2009) (130)
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. (2020) (129)
- Achieving optimal outcomes after radical prostatectomy. (2005) (126)
- Association of p53 mutations with metastatic prostate cancer. (1995) (126)
- The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. (2014) (126)
- Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. (2003) (125)
- Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. (2011) (125)
- The clinical features of anterior prostate cancers (2006) (118)
- A multi-institutional evaluation of active surveillance for low risk prostate cancer. (2013) (115)
- Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. (1999) (115)
- Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer (2012) (113)
- Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%. (2007) (112)
- Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study (2008) (111)
- Role of salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. (2005) (110)
- Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population. (2008) (109)
- Prostate cancer, version 1.2014. (2013) (108)
- Transforming growth factor-β1: Comparative immunohistochemical localization in human primary and metastatic prostate cancer (1995) (107)
- Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis. (2012) (107)
- Southwest Oncology Group Study of paclitaxel and carboplatin for advanced transitional-cell carcinoma: the importance of survival as a clinical trial end point. (2000) (106)
- The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end point. (2010) (101)
- Incontinence after Prostate Treatment: AUA/SUFU Guideline. (2019) (100)
- Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. (2008) (99)
- Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram (2008) (99)
- Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy. (2009) (98)
- Blunt renal trauma in the pediatric population: indications for radiographic evaluation. (1994) (96)
- Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer. (1997) (95)
- Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. (2010) (93)
- Long-term outcomes after high-dose postprostatectomy salvage radiation treatment. (2012) (91)
- Xanthogranulomatous pyelonephritis: clinical findings and surgical considerations. (1994) (91)
- Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. (2011) (90)
- Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. (2017) (90)
- Association of Cysteine-Rich Secretory Protein 3 and β-Microseminoprotein with Outcome after Radical Prostatectomy (2007) (88)
- Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. (2012) (86)
- Nomograms as predictive models. (2002) (82)
- Recovery of urinary function after radical prostatectomy: predictors of urinary function on preoperative prostate magnetic resonance imaging. (2011) (82)
- Preoperative predictive model of recovery of urinary continence after radical prostatectomy (2015) (81)
- Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy (2011) (80)
- Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study. (2004) (80)
- Do margins matter? The influence of positive surgical margins on prostate cancer-specific mortality. (2014) (79)
- Androgen deprivation therapy and estrogen deficiency induced adverse effects in the treatment of prostate cancer (2009) (78)
- Back to baseline: erectile function recovery after radical prostatectomy from the patients' perspective. (2013) (77)
- 1574: Is Focal Therapy Reasonable in Patients with Early Stage Prostate Cancer (CAP) - an Analysis of Radical Prostatectomy (RP) Specimens (2006) (76)
- Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy. (1994) (76)
- Nomogram incorporating PSA level to predict cancer‐specific survival for men with clinically localized prostate cancer managed without curative intent (2008) (75)
- Androgen deprivation and thromboembolic events in men with prostate cancer (2012) (75)
- Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. (1993) (74)
- Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1. (2020) (73)
- Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer (2009) (73)
- Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. (2010) (70)
- Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy. (2010) (70)
- A multi-institutional evaluation of active surveillance for low risk prostate cancer. (2009) (68)
- Oncologic outcome and patterns of recurrence after salvage radical prostatectomy. (2009) (68)
- The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance. (2016) (68)
- Reverse stage shift at a tertiary care center (2011) (67)
- Variations among experienced surgeons in cancer control after open radical prostatectomy. (2010) (66)
- Modified technique for neurovascular bundle preservation during radical prostatectomy: association between technique and recovery of erectile function (2008) (65)
- Radical prostatectomy: positive surgical margins matter. (2013) (65)
- Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making. (2014) (65)
- Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. (2019) (64)
- Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence? (2006) (63)
- Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. (2006) (63)
- Impact of Therapy on Genomics and Transcriptomics in High-Risk Prostate Cancer Treated with Neoadjuvant Docetaxel and Androgen Deprivation Therapy (2017) (62)
- Clinical stage T1c prostate cancer: evaluation with endorectal MR imaging and MR spectroscopic imaging. (2009) (62)
- Susceptibility Loci Associated with Prostate Cancer Progression and Mortality (2010) (61)
- Bone health in men receiving androgen deprivation therapy for prostate cancer. (2007) (61)
- Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer. (2000) (60)
- Serum testosterone levels in African-American and white men undergoing prostate biopsy. (1999) (60)
- Periprostatic adipose inflammation is associated with high-grade prostate cancer (2017) (60)
- Factors Predicting Early Return of Continence After Radical Prostatectomy (2010) (60)
- Diagnosis of Extracapsular Extension of Prostate Cancer on Prostate MRI: Impact of Second-Opinion Readings by Subspecialized Genitourinary Oncologic Radiologists. (2015) (60)
- Are We Improving Erectile Function Recovery After Radical Prostatectomy? Analysis of Patients Treated over the Last Decade. (2019) (60)
- Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL. (2005) (58)
- Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer. (2000) (58)
- Radiographic evaluation of adult patients with blunt renal trauma. (1992) (57)
- Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins? (2005) (56)
- The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. (2007) (56)
- Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. (2007) (56)
- Validation study of a web-based assessment of functional recovery after radical prostatectomy (2010) (56)
- The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. (2016) (56)
- Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection (2011) (55)
- Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. (2007) (54)
- The natural history of noncastrate metastatic prostate cancer after radical prostatectomy. (2007) (54)
- Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum (2006) (54)
- Progressive prostate cancer associated with use of megestrol acetate administered for control of hot flashes. (1999) (53)
- Cancer‐specific survival and predictors of prostate‐specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy (2006) (53)
- Long‐term follow‐up of 3‐month neoadjuvant hormone therapy before radical prostatectomy in a randomized trial (2010) (53)
- The association between nerve sparing and a positive surgical margin during radical prostatectomy. (2015) (53)
- Role of Changes in Magnetic Resonance Imaging or Clinical Stage in Evaluation of Disease Progression for Men with Prostate Cancer on Active Surveillance. (2019) (52)
- The predictive value of prostate cancer biomarkers depends on age and time to diagnosis: Towards a biologically‐based screening strategy (2007) (52)
- Time course of recovery of erectile function after radical retropubic prostatectomy: does anyone recover after 2 years? (2010) (52)
- Robotic-assisted prostatectomy: is there truth in advertising? (2008) (51)
- Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy? (2005) (51)
- Limited versus Extended Pelvic Lymph Node Dissection for Prostate Cancer: A Randomized Clinical Trial. (2021) (51)
- Urological evaluation and management of renal-proximity stab wounds. (1993) (51)
- Estrogenic side effects of androgen deprivation therapy. (2007) (50)
- Changes in pelvic organ prolapse surgery in the last decade among United States urologists. (2014) (50)
- Testicular microlithiasis as a predictor of intratubular germ cell neoplasia. (1996) (49)
- African‐American race is a predictor of prostate cancer detection: incorporation into a pre‐biopsy nomogram (2006) (49)
- Age, obesity, medical comorbidities and surgical technique are predictive of symptomatic anastomotic strictures after contemporary radical prostatectomy. (2011) (49)
- Longitudinal assessment of quality of life after surgery, conformal brachytherapy, and intensity-modulated radiation therapy for prostate cancer. (2016) (49)
- Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy (2007) (49)
- Radical retropubic prostatectomy: limited benefit of autologous blood donation. (1995) (48)
- A case of simultaneous bilateral nonseminomatous testicular tumors in persistent müllerian duct syndrome. (1992) (48)
- Subjective characterization of nerve sparing predicts recovery of erectile function after radical prostatectomy: defining the utility of a nerve sparing grading system. (2011) (47)
- Effect of repeated prostate biopsies on erectile function in men on active surveillance for prostate cancer. (2014) (47)
- 553: Comprehensive Prospective Comparative Analysis of Outcomes between Open and Laparoscopic Radical Prostatectomy (2007) (47)
- Major shifts in the treatment and prognosis of prostate cancer due to changes in pathological diagnosis and grading (2007) (47)
- Angiographic embolization of renal stab wounds. (1992) (46)
- Other biomarkers for detecting prostate cancer (2010) (46)
- Pubovesical fistula: a rare complication after treatment of prostate cancer. (2012) (46)
- Locally advanced prostate cancer: a population‐based study of treatment patterns (2012) (46)
- Bilateral cavernous nerve interposition grafting during radical retropubic prostatectomy: Memorial Sloan-Kettering Cancer Center experience. (2007) (46)
- Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures. (2012) (46)
- Midurethral sling is the dominant procedure for female stress urinary incontinence: analysis of case logs from certifying American Urologists. (2013) (45)
- Prostatic specific antigen for prostate cancer detection. (2009) (45)
- Salvage therapy for locally recurrent prostate cancer after external beam radiotherapy (2004) (45)
- Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study. (2016) (44)
- Do high-volume hospitals and surgeons provide better care in urologic oncology? (2009) (44)
- Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening. (2003) (44)
- A Pilot Study of a Multimodal Treatment Paradigm to Accelerate Drug Evaluations in Early-stage Metastatic Prostate Cancer. (2017) (42)
- Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer. (2013) (42)
- Rationale for zoledronic acid therapy in men with hormone-sensitive prostate cancer with or without bone metastasis. (2006) (42)
- p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer (2009) (42)
- Penetrating trauma to the male external genitalia. (1998) (42)
- Systematic Review of Systemic Therapies and Therapeutic Combinations with Local Treatments for High-risk Localized Prostate Cancer. (2019) (41)
- Long-Term Outcomes of Active Surveillance for Prostate Cancer - The Memorial Sloan Kettering Cancer Center Experience. (2019) (41)
- The prognostic significance of capsular incision into tumor during radical prostatectomy. (2011) (41)
- Prostate Cancer Topography and Patterns of Lymph Node Metastasis (2010) (41)
- The incidence and implications of renal cell carcinoma in cadaveric renal transplants at the time of organ recovery. (1999) (40)
- Clinical characteristics and biopsy specimen features in African-American and white men without prostate cancer. (1998) (39)
- Localizing sites of disease in patients with rising serum prostate-specific antigen up to 1ng/ml following prostatectomy: How much information can conventional imaging provide? (2016) (39)
- Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy (2009) (39)
- Germline BRCA mutation does not prevent response to taxane‐based therapy for the treatment of castration‐resistant prostate cancer (2012) (39)
- Bone Health and Bone-Targeted Therapies for Prostate Cancer: ASCO Endorsement of a Cancer Care Ontario Guideline. (2020) (38)
- Significance and management of positive surgical margins at the time of radical prostatectomy (2014) (37)
- Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. (2005) (37)
- Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer. (1995) (36)
- Characterization and three-dimensional localization of cancerous prostate tissue using backscattering scanning polarization imaging and independent component analysis. (2012) (36)
- Prospective Study of the Radiolabeled GRPR Antagonist BAY86-7548 for Positron Emission Tomography/Computed Tomography Imaging of Newly Diagnosed Prostate Cancer. (2019) (35)
- Prostate cancer diagnosed after repeat biopsies have a favorable pathological outcome but similar recurrence rate. (2006) (35)
- Prostate biopsy techniques and indications: when, where, and how? (2002) (34)
- Radical prostatectomy for high-risk prostate cancer (2008) (34)
- Prognostic impact of subclassification of radical prostatectomy positive margins by linear extent and Gleason grade. (2013) (34)
- Local progression among men with conservatively treated localized prostate cancer: results from the Transatlantic Prostate Group. (2008) (34)
- Near Infrared Photonic Finger Imager for Prostate Cancer Screening (2011) (33)
- Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series. (2012) (32)
- Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer (2018) (32)
- Is year of radical prostatectomy a predictor of outcome in prostate cancer? (2004) (32)
- Electronic patient self-assessment and management (SAM): a novel framework for cancer survivorship (2010) (32)
- Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome (2007) (32)
- Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy (2005) (31)
- Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. (2005) (31)
- Clinical Usefulness of Total Length of Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer (2019) (31)
- Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer (2014) (31)
- Impact of Pelvic Lymph Node Dissection and Its Extent on Perioperative Morbidity in Patients Undergoing Radical Prostatectomy for Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis. (2021) (31)
- Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate. (1999) (31)
- Penetrating trauma to the male external genitalia (1998) (31)
- Radical prostatectomy shortly after prostate biopsy does not affect operative difficulty or efficacy. (2007) (30)
- Anatomic segmentation improves prostate cancer detection with artificial neural networks analysis of 1H magnetic resonance spectroscopic imaging (2014) (30)
- Clinical Characteristics and Biopsy Specimen Features in African-American and White Men Without Prostate Cancer (1998) (30)
- A case‐mix‐adjusted comparison of early oncological outcomes of open and robotic prostatectomy performed by experienced high volume surgeons (2013) (30)
- Detection of Lymph Node Metastases with SERRS Nanoparticles (2016) (29)
- Fat density in renal cell carcinoma: demonstration with computerized tomography. (1997) (29)
- Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer. (2020) (29)
- Genotype–phenotype analysis for the polymorphic CA repeat in the insulin-like growth factor-I (IGF-I) gene (2002) (29)
- How do you know if you are any good? A surgeon performance feedback system for the outcomes of radical prostatectomy. (2012) (29)
- Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance. (2014) (29)
- Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance? (2016) (28)
- Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer. (2015) (28)
- The evolution of chemotherapy for the treatment of prostate cancer. (2017) (28)
- Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center. (2020) (28)
- Fifteen-year survival and recurrence rates after radiotherapy for localized prostate cancer. (1997) (28)
- Amphiregulin Is Coordinately Expressed with Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Interstitial Smooth Muscle of the Human Prostate1. (1999) (27)
- The depth of the prostatic apex is an independent predictor of positive apical margins at radical prostatectomy (2010) (27)
- Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer. (2012) (27)
- Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. (2019) (27)
- Tensile strength of cadaveric fascia lata compared to small intestinal submucosa using suture pull through analysis. (2001) (27)
- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management (2022) (26)
- Is it necessary to remove the seminal vesicles completely at radical prostatectomy? decision curve analysis of European Society of Urologic Oncology criteria. (2009) (26)
- What is the optimal management of high risk, clinically localized prostate cancer? (2010) (26)
- Renal cell carcinoma in an intrathoracic kidney: radiographic findings and surgical considerations. (1999) (26)
- Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors. (2009) (26)
- The very-high-risk prostate cancer: a contemporary update (2016) (25)
- Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement? (2002) (25)
- Defining the impact of vascular risk factors on erectile function recovery after radical prostatectomy (2013) (25)
- Inhibition of Circulating Dipeptidyl Peptidase 4 Activity in Patients with Metastatic Prostate Cancer* (2014) (25)
- Prostate size and adverse pathologic features in men undergoing radical prostatectomy. (2014) (25)
- Critical appraisal of outcomes following open radical prostatectomy (2009) (24)
- Testosterone in prostate cancer: the Bethesda consensus (2012) (24)
- The evolution of chemotherapy for the treatment of prostate cancer (2017) (24)
- Evaluation of prediagnostic prostate‐specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively (2011) (24)
- Cloning and characterization of the prostate‐specific membrane antigen promoter (1999) (23)
- Clinical features and management of BRCA1 and BRCA2-associated prostate cancer. (2014) (23)
- Race is not an independent predictor of positive surgical margins after radical prostatectomy. (1999) (23)
- Radical prostatectomy in patients infected with human immunodeficiency virus (2006) (23)
- Costs of medical care after open or minimally invasive prostate cancer surgery (2012) (23)
- Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis (2016) (22)
- Evaluation of molecular forms of prostate‐specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy (2009) (22)
- Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy (2021) (22)
- Current Status of MRI and PET in the NCCN Guidelines for Prostate Cancer. (2019) (22)
- MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer. (2013) (22)
- Influence of hepatic function on serum levels of prostate specific antigen. (1997) (21)
- Current Recommendations for Delaying Renal Transplantation after Localized Prostate Cancer Treatment: Are They Still Appropriate? (2004) (21)
- Algorithms for prostate-specific antigen recurrence after treatment of localized prostate cancer. (2003) (21)
- Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance. (2015) (21)
- Zoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer. (2010) (21)
- Long-term adverse effects after curative radiotherapy and radical prostatectomy: population-based nationwide register study (2016) (20)
- Chronology of erectile function in patients with early functional erections following radical prostatectomy. (2010) (20)
- Impact of ethnicity on surgical margins at radical prostatectomy (2009) (20)
- Prognostic significance of lymphovascular invasion in radical prostatectomy specimens (2011) (20)
- Topography of Prostate Cancer Recurrence After Radiation Therapy: A Detailed Mapping Study of Salvage Radical Prostatectomy Specimens. (2017) (19)
- Clinical Usefulness of Prostate and Tumor Volume Related Parameters following Radical Prostatectomy for Localized Prostate Cancer (2019) (19)
- Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis. (2011) (19)
- Dietary manipulation, ethnicity, and serum PSA levels. (2003) (19)
- Prostate-specific antigen kinetics and outcomes in patients with bone metastases from castration-resistant prostate cancer treated with or without zoledronic acid. (2014) (19)
- Long‐term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high‐risk prostate cancer (2015) (19)
- Effect of zoledronic acid on bone pain and skeletal morbidity in patients with advanced prostate cancer; analysis by baseline pain (2005) (18)
- Prostate-specific antigen doubling time as a prognostic marker in prostate cancer (2005) (18)
- Risk of incisional hernia after minimally invasive and open radical prostatectomy. (2013) (18)
- Nodal counts during pelvic lymph node dissection for prostate cancer: an objective indicator of quality under the influence of very subjective factors (2012) (18)
- Use of an anti-ras ribozyme to alter the malignant phenotype of a human bladder cancer cell line. (1996) (18)
- Susceptibility loci associated with prostate cancer progression and mortality. (2010) (17)
- Nilutamide response after flutamide failure in post-orchiectomy progressive prostate cancer. (1998) (17)
- Prostate cancer screening (2017) (17)
- Location and number of positive surgical margins as prognostic factors of biochemical recurrence after salvage radiation therapy after radical prostatectomy (2010) (17)
- Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram. (2008) (16)
- Contemporary Patterns of Care and Outcomes of Men Found to Have Lymph Node Metastases at the Time of Radical Prostatectomy (2017) (16)
- Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy. (2019) (16)
- An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy. (2010) (16)
- Clinical stage T1c prostate cancer: Pathologic outcomes following radical prostatectomy in black and white men (2002) (16)
- Gleason score and pretreatment prostate-specific antigen in survival among patients with stage D2 prostate cancer (2004) (15)
- Primary seminal vesicle adenocarcinoma. (2011) (15)
- An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality (2015) (15)
- Clinical Findings and Treatment Outcomes in Patients with Extraprostatic Extension Identified on Prostate Biopsy. (2016) (15)
- The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature. (2020) (15)
- Race is not a predictor of prostate cancer detection on repeat prostate biopsy. (2004) (15)
- Salvage radical prostatectomy for recurrence of prostate cancer after radiation therapy (2003) (15)
- Impact of socioeconomic factors on prostate cancer outcomes in black patients treated with surgery. (2008) (14)
- Insignificant disease among men with intermediate-risk prostate cancer (2014) (14)
- An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. (2016) (14)
- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up (2022) (14)
- Racial variation in prostate specific antigen in a large cohort of men without prostate cancer. (2001) (14)
- Neoadjuvant Treatment of High-Risk, Clinically Localized Prostate Cancer Prior to Radical Prostatectomy (2016) (13)
- PROSTATE CANCER-SPECIFIC MORTALITY AFTER RADICAL PROSTATECTOMY FOR PATIENTS TREATED IN THE PROSTATE- SPECIFIC ANTIGEN ERA (2008) (13)
- Locally ablative therapies for primary radiation failures: A review and critical assessment of the efficacy (2007) (13)
- Erectile Function Recovery after Radical Prostatectomy in Men with High Risk Features. (2016) (13)
- Outcomes after radical prostatectomy in men receiving previous pelvic radiation for non‐prostate malignancies (2009) (12)
- Can transrectal needle biopsy be optimised to detect nearly all prostate cancer with a volume of ≥0.5 mL? A three‐dimensional analysis (2013) (12)
- Race is not independently associated with a positive prostate biopsy in men suspected of having prostate cancer. (1999) (12)
- Trends in radical prostatectomy (2009) (12)
- How do you tell whether a change in surgical technique leads to a change in outcome? (2010) (12)
- Role of radical prostatectomy in the treatment of high-risk prostate cancer (2008) (12)
- PTEN loss with ERG-Negative Status is Associated with Lethal Disease after Radical Prostatectomy. (2020) (11)
- Seminal vesicle involvement at salvage radical prostatectomy (2013) (11)
- Prostate MRSI predicts outcome in radical prostatectomy patients. (2016) (11)
- Squamous Cell Carcinoma of the Penis: A Retrospective Review of Forty-Five Patients in Northwest Louisiana (2002) (11)
- Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer (2013) (11)
- Predictors of recovery of erectile function after unilateral cavernous nerve graft reconstruction at radical retropubic prostatectomy. (2010) (11)
- Surgery Insight: optimizing open nerve-sparing radical prostatectomy techniques for improved outcomes (2007) (11)
- Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series (2018) (10)
- RENAL CELL CARCINOMA DETECTED IN A CADAVERIC DONOR AFTER ORTHOTOPIC LIVER AND CONTRALATERAL RENAL TRANSPLANTATION IN TWO RECIPIENTS: Four-year Follow-up (2001) (10)
- Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer. (2016) (10)
- Accuracy of post‐radiotherapy biopsy before salvage radical prostatectomy (2013) (10)
- Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3 + 4 prostate cancer (2015) (10)
- Early diagnosis and treatment of prostate cancer. (2001) (10)
- Association of anesthesia technique for radical prostatectomy with biochemical recurrence: a retrospective cohort study (2014) (10)
- Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue (2009) (10)
- Robotic prostatectomy: the rise of the machines or judgment day. (2012) (10)
- CALGB 90203 (Alliance): Radical prostatectomy (RP) with or without neoadjuvant chemohormonal therapy (CHT) in men with clinically localized, high-risk prostate cancer (CLHRPC). (2019) (10)
- Clinical and Biopsy Specimen Features in Black and White Men With Clinically Localized Prostate Cancer (2000) (9)
- Seminal vesicle abscess due to tuberculosis: role of tissue culture in making the diagnosis. (1999) (9)
- Association between number of prostate biopsies and patient‐reported functional outcomes after radical prostatectomy: implications for active surveillance protocols (2016) (9)
- Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort (2021) (9)
- Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy. (2020) (9)
- Variation in serum prostate‐specific antigen levels in men with prostate cancer managed with active surveillance (2016) (8)
- Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomy (2012) (8)
- Active surveillance for prostate cancer with selective delayed definitive therapy. (2005) (8)
- Contemporary Management of Hemorrhage After Minimally Invasive Radical Prostatectomy. (2019) (8)
- Radiographic assessment of blunt renal trauma. (1991) (8)
- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. Part III: Principles of Radiation and Future Directions (2022) (8)
- Postoperative systems models more accurately predict risk of significant disease progression than standard risk groups and a 10‐year postoperative nomogram: potential impact on the receipt of adjuvant therapy after surgery (2012) (8)
- A phase II study combining ipilimumab and degarelix with or without radical prostatectomy (RP) in men with newly diagnosed metastatic noncastration prostate cancer (mNCPC) or biochemically recurrent (BR) NCPC. (2017) (8)
- A MULTI-INSTITUTIONAL COHORT OF ACTIVE SURVEILLANCE FOR LOW-RISK LOCALIZED PROSTATE CANCER (2008) (8)
- Can pelvic node dissection at radical prostatectomy influence the nodal recurrence at salvage lymphadenectomy for prostate cancer? (2018) (7)
- Erectile Function and Sexual Satisfaction: The Importance of Asking About Sexual Desire. (2019) (7)
- Development of a Nomogram Model Predicting Current Bone Scan Positivity in Patients Treated with Androgen-Deprivation Therapy for Prostate Cancer (2014) (7)
- Critical elements in fellowship training. (2009) (7)
- Genetic factors associated with prostate cancer conversion from active surveillance to treatment (2021) (7)
- Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? (2011) (7)
- Relationship between surgical volume and patient outcomes (2015) (7)
- NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023. (2022) (7)
- 796: Surgeon Volume is Predictor of Improved Outcomes in Radical Prostatectomy Patients (2004) (7)
- The association between tumour density and prostate cancer recurrence following radical prostatectomy. (2011) (7)
- Undifferentiated sex cord/stromal testis tumor. (2000) (7)
- Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer (2004) (6)
- Does neurovascular bundle preservation at the time of radical prostatectomy improve urinary continence? (2007) (6)
- Surgical management of urethral strictures based on etiology. Where do urethral stents fit in? (1992) (6)
- Duration of response to androgen deprivation therapy and survival after subsequent biochemical relapse in men initially treated with radical prostatectomy. (2004) (6)
- Lower urinary tract symptoms, benign prostatic hyperplasia, and prostate cancer: seek and ye shall find. (2013) (6)
- Screening prostate cancer using a portable near infrared scanning imaging unit with an optical fiber-based rectal probe (2012) (6)
- Can We Improve the Preoperative Prediction of Prostate Cancer Recurrence With Multiparametric MRI? (2019) (6)
- Biopsy Core Features are Poor Predictors of Adverse Pathology in Men with Grade Group 1 Prostate Cancer (2017) (6)
- Isolated pulmonary metastases from prostatic adenocarcinoma. (1993) (6)
- Management and evaluation of localized amyloidosis of the bladder: two case reports. (1994) (6)
- Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy. (2009) (6)
- Impact of the radical prostatectomy surgical technique and surgeon experience on freedom from cancer recurrence. (2006) (6)
- 572Long-term reduction of bone pain and skeletal morbidity with zoledronic acid in patients with prostate cancer and bone metastases (2005) (6)
- 662: Long-Term Outcome Following Radical Prostatectomy in Men with Clinical T3 Prostate Cancer (2005) (6)
- Predicting time to metastatic progression from biochemical recurrence after radical prostatectomy. (2004) (6)
- Impalpable prostate cancer: clinicopathological features. (1996) (6)
- Granulomatous mass in a nonrefluxing renal unit after bacillus Calmette-Guerin therapy for bladder cancer. (1997) (5)
- Tissue and cell—cell interactions in prostate cancer progression (1995) (5)
- Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy (2016) (5)
- Minimally invasive vs open radical prostatectomy. (2010) (5)
- PRIMARY PROSTATE HIFU WITHOUT PRETREATMENT HORMONE THERAPY: BIOCHEMICAL SURVIVAL OF 468 PATIENTS TRACKED WITH THE @-REGISTRY (2009) (5)
- Ambulatory Extended Recovery: Safely Transitioning to Overnight Observation for Minimally Invasive Prostatectomy (2015) (5)
- Maintaining bone health in prostate cancer throughout the disease continuum. (2010) (5)
- Large granular cell tumor of the penis in a 53-year-old man with coexisting prostate cancer. (2002) (5)
- Trends and Clinical Practice Patterns of Sacral Neuromodulation for Overactive Bladder (2017) (5)
- The prevalence of persistent prostate cancer after radiotherapy detected at radical cystoprostatectomy for bladder cancer. (2014) (5)
- Pelvimetric dimensions do not impact upon nerve sparing or erectile function recovery in patients undergoing radical retropubic prostatectomy. (2011) (5)
- In Organ-confined Prostate Cancer, Tumor Quantitation Not Found to Aid in Prediction of Biochemical Recurrence (2019) (5)
- RISK-ADJUSTED ANALYSIS OF POSITIVE SURGICAL MARGINS FOLLOWING LAPAROSCOPIC AND RETROPUBIC RADICAL PROSTATECTOMY (2006) (5)
- An assessment of Prostate Cancer Research International: Active Surveillance (PRIAS) criteria for active surveillance of clinically low-risk prostate cancer patients. (2017) (5)
- International Multi-Site Initiative to Develop an MRI-Inclusive Nomogram for Side-Specific Prediction of Extraprostatic Extension of Prostate Cancer (2021) (5)
- Outcomes following negative prostate biopsy for patients with persistent disease after radiotherapy for prostate cancer. (2008) (5)
- Salvage Pelvic Lymph Node Dissection for Nodal Recurrence After Radical Prostatectomy Results in Minimal Clinical Benefit. (2020) (4)
- LBA-12 CALGB 90203 (ALLIANCE): RADICAL PROSTATECTOMY WITH OR WITHOUT NEOADJUVANT CHEMOHORMONAL THERAPY IN MEN WITH CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER (2019) (4)
- Cancers of the Urinary Tract (1998) (4)
- 1398: Effects of Patient Risk on the Learning Curve for Radical Prostatectomy: Evidence that Recurrence in Organ-Confined Cancer is Largely Related to Inadequate Surgical Technique (2007) (4)
- Outcomes of salvage radical prostatectomy following more than one failed local therapy (2018) (4)
- Metacure: Multi-arm multimodality therapy for very high risk localized and low volume metastatic prostatic adenocarcinoma. (2019) (4)
- The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal after Radical Prostatectomy: Clinically-Integrated, Cluster, Randomized Trial. (2021) (4)
- Does Subclassification of Pathologically Organ Confined (pT2) Prostate Cancer Provide Prognostic Discrimination of Outcomes after Radical Prostatectomy? (2018) (4)
- 125 IMPACT OF STATIN USE ON PATHOLOGIC FEATURES IN MEN TREATED WITH RADICAL PROSTATECTOMY (2010) (4)
- Comparison of Two Methods for Assessing Erectile Function Before Radical Prostatectomy. (2019) (4)
- The probability of a positive bone scan in patients who were treated with adrogen ablasio therapy for rising PSA after radical prostatectomy. (2006) (4)
- VALIDATION OF A NOMOGRAM FOR PREDICTING DISEASE RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER (1999) (4)
- 1753 COMPARATIVE EFFECTIVENESS OF SURGICAL TREATMENTS FOR PROSTATE CANCER: A POPULATION-BASED ANALYSIS OF POSTOPERATIVE OUTCOMES (2010) (4)
- The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices (2014) (4)
- Variation of Serum Prostate-Specific Antigen Levels (2013) (4)
- The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. (2016) (4)
- Cancer treatment-induced bone loss (CTIBL) in prostate cancer: Pathophysiology, preclinical findings, and treatment with zoledronic acid (2004) (4)
- 1190: Studies on Androgen Deprivation Therapy for a Rising PSA Prostatectomy: Development of Castrate Metastasis (Hormonally Refractory Prostate Cancer) (2006) (4)
- 995 ANALYSIS OF STATIN MEDICATION, GENETIC VARIATION AND PROSTATE CANCER OUTCOMES (2011) (4)
- "PSA Surveillance in the Septuagenarian": A Proposed New Terminology for Clinical Follow-up to Assess Risk of Prostate Cancer in Men Aged 70 Years and Older. (2020) (3)
- The devil is in the details. (2011) (3)
- Management of Recurrent Prostate Cancer After Radiotherapy: Results From Calgb 9687, a Contemporary Prospective Multi-Institutional Salvage Radical Prostatectomy Series (2008) (3)
- High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy (2003) (3)
- Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer. (2022) (3)
- 128 TEMPORAL TRENDS IN THE OPERATIVE MANAGEMENT OF PELVIC LYMPH NODES IN PATIENTS RECEIVING OPEN OR MINIMALLY INVASIVE RADICAL PROSTATECTOMY (2010) (3)
- 671: Defining Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy: A Proposal for a Standardized Definition (2005) (3)
- Re: Use of Prostate Systematic and Targeted Biopsy on the Basis of Multiparametric MRI in Biopsy-naive Patients (MRI-FIRST): A Prospective, Multicentre, Paired Diagnostic Study. (2019) (3)
- 750 RADICAL PROSTATECTOMY: A NON-RANDOMIZED COMPARATIVE ANALYSIS OF OUTCOMES BETWEEN THE OPEN AND LAPAROSCOPIC APPROACH (2007) (3)
- 856: The Chronology of Erectile Function Loss after Radical Prostatectomy (2007) (3)
- Salvage therapies after radiation therapy. (2012) (3)
- RACIAL DISPARITIES IN THE TREATMENT AND SURVIVAL OF LOCALLY ADVANCED PROSTATE CANCER PATIENTS (2009) (3)
- Pretreatment nomogram predicting the long-term risk of metastatic progression of prostate cancer after radical prostatectomy (2005) (3)
- 17: The Concordance between a Systematically Administered Physician Reported Assessment of Function and a Health-Related Quality of Life Instrument (2007) (3)
- Clinically Localized Prostate Cancer: AUA/ASTRO Guideline. (2022) (3)
- Radical prostatectomy: Surgical perspectives (2014) (3)
- 749 COMPARATIVE ANALYSIS OF THE IMPACT OF PROSTATE VOLUME ON POSITIVE SURGICAL MARGIN INCIDENCE AND LOCATION BETWEEN OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY (2007) (2)
- 918 Prostate-specific antigen kinetics in patients with bone metastases from castration-resistant prostate cancer receiving zoledronic acid therapy (2012) (2)
- PD50-07 SAFETY OF TESTOSTERONE THERAPY IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2016) (2)
- MP86-11 IS THERE A RELATIONSHIP BETWEEN PHOSPHODIESTERASE TYPE 5 INHIBITORS (PDE5I) AND PROSTATE CANCER BIOCHEMICAL RECURRENCE? (2016) (2)
- Effective management of localized prostate cancer: first, do no harm. (2013) (2)
- Robotic salvage prostatectomy: underused but not for the inexperienced. (2013) (2)
- Routine Postoperative Hemoglobin Assessment Poorly PredictsTransfusion Requirement among Patients Undergoing Minimally Invasive Radical Prostatectomy. (2020) (2)
- 212: Role of Surgeon and Surgeon Volume in Erectile Function Recovery after Radical Prostatectomy (2006) (2)
- Predicting progression in patients followed with active surveillance for low-risk prostate cancer. (2014) (2)
- What has to happen before we report radical prostatectomy outcomes of individual surgeons to the public? (2011) (2)
- INSIGHTS INTO THE IMPACT OF NERVE-SPARING STATUS DURING RADICAL PROSTATECTOMY: VALIDATING OF A NERVE SPARING SCORING SYSTEM (2009) (2)
- Relationship Between Age, Comorbidity, and the Prevalence of Erectile Dysfunction. (2022) (2)
- PREDICTORS OF URINARY CONTINENCE AFTER CONTEMPORARY RADICAL PROSTATECTOMY (2008) (2)
- 849 DEFINING BIOCHEMICAL FAILURE FOLLOWING HIGH INTENSITY FOCUSED ULTRASOUND OF THE PROSTATE: THE STUTTGART DEFINITION (2009) (2)
- Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach (2022) (2)
- 1137: Natural History of Biochemically-Recurrent Castrate-Resistant Disease in Men Treated with Maximal Androgen Blockage for a Rising PSA after Radical Prostatectomy (2005) (2)
- A randomized trial on pelvic lymph node dissection versus no lymph node dissection at radical prostatectomy: Report of a trial in progress. (2022) (2)
- Clinical Stage T1c Prostate Cancer: Evaluation with Endorectal MRImagingandMRSpectroscopic (2009) (2)
- Prostate-specific Antigen Density Cutoff of 0.15 ng/ml/cc to Propose Prostate Biopsies to Patients with Negative Magnetic Resonance Imaging: Efficient Threshold or Legacy of the Past? (2022) (2)
- Have urinary function outcomes after radical prostatectomy improved over the past decade? (2021) (2)
- 1661: Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy: A New Preoperative Nomogram (2005) (2)
- 559: Impact of Fellowship Training on Oncological Outcomes after Radical Prostatectomy (2007) (2)
- Clinical utility of subclassifying positive surgical margins at radical prostatectomy (2021) (2)
- Localization of higher grade tumor foci in potential candidates for active surveillance who opt for radical prostatectomy (2013) (2)
- Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer. (2016) (2)
- Preservation of sexual function after treatment for prostate cancer (2008) (2)
- Prostate cancer metastatic only to the penis. (1997) (2)
- Radical prostatectomy for clinical T3 disease: expanding indications while optimizing cancer control and quality of life (2007) (2)
- 1244 THE IMPACT OF REPEAT BIOPSIES ON INFECTIOUS COMPLICATIONS IN MEN WITH PROSTATE CANCER ON ACTIVE SURVEILLANCE: A PROSPECTIVE STUDY (2013) (2)
- 337 CONTEMPORARY OPEN AND ROBOTIC RADICAL PROSTATECTOMY PRACTICE PATTERNS AMONG UNITED STATES UROLOGISTS (2011) (2)
- Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer (2022) (2)
- 856: A Pretreatment Nomogram for Predicting the Need for Additional Therapy Following Radical Prostatectomy for Prostate Cancer (2004) (2)
- Establishing a neoadjuvant platform for developing targeted agents: Degarelix prior to prostatectomy for patients with intermediate- and high-risk prostate cancer. (2014) (2)
- COMPLICATIONS OF RADICAL PROSTATECTOMY: ANALYSIS OF PREDICTORS (2008) (2)
- 440: Clinical Course and Response to First-Line Androgen Deprivation Therapy in Patients with PSA-Progression After Radical Prostatectomy (2004) (2)
- 433 Long-term oncological outcomes of salvage radical prostatectomy for radio-recurrent/persistent prostate cancer after radiation therapy (2016) (2)
- 145 Is there a Relationship between Phosphodiesterase Type 5 Inhibitors (PDE5i) and Prostate Cancer Biochemical Recurrence (2017) (2)
- 383: Which Definition of PSA Doubling Time or Velocity best Predicts Outcome after Radical Prostatectomy? (2007) (2)
- 1430: Association of Cysteine-Rich Secretory Protein 3 and Beta-Microseminoprotein with Outcome after Radical Prostatectomy: Evaluation with a Tissue Microarray of 947 Primary Prostate Cancers (2007) (2)
- Estimating patient health in prostate cancer treatment counseling (2020) (2)
- The Efficacy of Multiparametric Magnetic Resonance Imaging and MRI-Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance (2017) (2)
- Li-Fraumeni Syndrome-related Malignancies Involving the Genitourinary Tract: Review of a Single-institution Experience. (2018) (2)
- PD32-04 CAN CONFIRMATORY BIOPSY BE SKIPPED FOR ACTIVE SURVEILLANCE PATIENTS WITH NEGATIVE MRI FINDINGS AND A LOW NUMBER OF POSITIVE CORES ON DIAGNOSTIC BIOPSY? (2015) (1)
- 738 PATIENT ASSESSED ERECTILE FUNCTION RECOVERY AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: HEAD-TO-HEAD PROSPECTIVE COMPARISON (2007) (1)
- Locally advanced prostate cancer: A population-based study of treatment patterns and predictors. (2009) (1)
- Addition of Prostate Volume and Prostate-specific Antigen Density to Memorial Sloan Kettering Cancer Center Prostate Cancer Nomograms (2021) (1)
- Re: Prostate Cancer–Specific Survival Following Salvage Radiotherapy versus Observation in Men with Biochemical Recurrence after Radical Prostatectomy (2009) (1)
- Standardization of patient-centered outcomes: less is more. (2015) (1)
- Photoselective Vaporization of the Prostate in the Management of Lower Urinary Tract Symptoms in Prostate Cancer Patients on Active Surveillance. (2021) (1)
- MP46-04 RESULTS OF THE PCM-204 PHASE 2B TRIAL OF PARTIAL-GLAND ABLATION FOR MEN WITH INTERMEDIATE-RISK PROSTATE CANCER WITH PADELIPORFIN (WST11 OR TOOKAD) VASCULAR-TARGETED PHOTODYNAMIC THERAPY (2021) (1)
- 1139: Predicting Time to Metastatic Progression from Biochemical Recurrence after Radical Prostatectomy (2005) (1)
- Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing. (2021) (1)
- 321: No Differences in Biochemical Recurrence between NO and NX Patients Subjected to Radical Prostatectomy: A Matched Analyses on 5977 Patients (2007) (1)
- Radical prostatectomy versus observation for prostate cancer. (2012) (1)
- PI-LBA08 PRELIMINARY ASSESSMENT OF A VALIDATED URINE EXOSOME ASSAY (EXDX PROSTATE (INTELLISCORE) FOR PREDICTING BIOCHEMICAL RECURRENCE POST-PROSTATECTOMY (2016) (1)
- Phase 2b trial results of padeliporfin (WST11 or Tookad) vascular-targeted photodynamic therapy for partial gland ablation in men with intermediate-risk prostate cancer. (2021) (1)
- Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment (2021) (1)
- Variation of Serum Prostate-Specific Antigen in Men with Prostate Cancer Managed with Active Surveillance (2017) (1)
- Combined androgen deprivation and radiation versus either modality alone or observation after radical prostatectomy in patients with pathologic node-positive prostate cancer: Analysis of a national hospital cancer registry database (2017) (1)
- 1085 REVERSE STAGE MIGRATION AT A TERTIARY CARE CENTER: ESCALATING RISK IN MEN UNDERGOING RADICAL PROSTATECTOMY ASSOCIATED WITH INCREASING USE OF ACTIVE SURVEILLANCE (2011) (1)
- Reply to Effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer: Do we have certainties today? (2019) (1)
- 616: Variations Among Experienced Surgeons and Cancer Control Rates after Radical Prostatectom (2007) (1)
- PD27-03 RADICAL PROSTATECTOMY AS A COMPONENT OF MULTIMODAL THERAPY FOR HIGHLY-SELECTED M1 PROSTATE CANCER PATIENTS (2014) (1)
- 807: Achieving Optimal Outcomes After Radical Prostatectomy (2004) (1)
- Lag time to adverse events after radical prostatectomy and curative radiotherapy. (2015) (1)
- Periprostatic adipose in fl ammation is associated with high-grade prostate cancer (2017) (1)
- Radical prostatectomy as a component of multimodal therapy for highly selected M1 prostate cancer patients. (2015) (1)
- Editorial comment on: first analysis of the long-term results with transrectal HIFU in patients with localized prostate cancer. (2008) (1)
- Quality improvement initiative to reduce variability and improve stewardship of antimicrobial prophylaxis for transrectal prostate needle biopsy (2019) (1)
- 1188: 15-year Cancer-Specific and Psa-Progression free Rates after Radical Prostatectomy (2004) (1)
- De Novo Urinary Storage Symptoms Are Common after Radical Prostatectomy: Incidence, Natural History and Predictors (2021) (1)
- High‐risk prostate cancer: too risky for the robotic learning curve (2013) (1)
- PD49-09 TESTOSTERONE THERAPY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2022) (1)
- 787: Predicting The 10-Year Probability of Prostate Cancer Recurrence: An Updated Postoperative Nomogram and a Suite of Nomograms for Patients who are Free of Disease at One to Five Years after Radical Prostatectomy (2004) (1)
- 491: Studies on Rising PSA After RP: Trends on Secondary Treatments (2006) (1)
- Expectant Management of Prostate Cancer (2012) (1)
- 855: Development of PRE and Post-Operative Nomograms for Erectile Function Recovery after Radical Prostatectomy (2007) (1)
- POD-05.08: Predicting the Long-Term Risk of Prostate Cancer-Specific Mortality After Radical Prostatectomy (2009) (1)
- Androgen Receptor Mutations in Prostate Cancer 1 (2000) (1)
- Development of a nomogram model using a very large sample of patients (pts) to predict the risk of 99mTc-bone scan (BS) positivity in pts receiving androgen deprivation therapy (ADT) for prostate cancer (PCa). (2012) (1)
- NCCN Prostate Cancer , Version 2 . 2014 Clinical Practice Guidelines in Oncology (2014) (1)
- MP53-20 ACCURACY OF MRI-TARGETED BIOPSY TO RECLASSIFY GLEASON GRADE IN MEN ON ACTIVE SURVEILLANCE (2015) (1)
- Neoadjuvant Systemic Therapy Prior to Radical Prostatectomy for Clinically Localized High-Risk Prostate Cancer (2022) (1)
- Prostate cancer: Science and clinical practice (2005) (1)
- Extensive disease among potential candidates for hemi‐ablative focal therapy for prostate cancer (2019) (1)
- 624 IMPACT OF THE SURGICAL APPROACH ON THE ONCOLOGICAL OUTCOME FOLLOWING RADICAL PROSTATECTOMY (2007) (1)
- 637P Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma (2021) (1)
- Multimodality imaging using proton magnetic resonance spectroscopic imaging and 18F-fluorodeoxyglucose-positron emission tomography in local prostate cancer (2017) (1)
- 1607: Longitudinal Evaluation of Molecular PSA Isoforms and Human Glandular Kallikrein 2 in Predicting Biochemical Failure following Radical Prostatectomy (2007) (1)
- Researchers The NCCN Prostate Cancer Clinical Practice Guidelines in OncologyTM (2010) (1)
- Association of Family History of Cancer with Clinical and Pathological Outcomes for Prostate Cancer Patients on Active Surveillance (2022) (1)
- Reply to Re: The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening. (2016) (1)
- 2576 A non-invasive urine exosome gene expression assay (Exo106) accurately predicts pathologic stage and grade in the prostatectomy specimen (2015) (1)
- Locally ablative therapies for primary radiation failures: A review and critical assessment of the efficacy (2007) (1)
- 470 DO MARGINS MATTER? THE INFLUENCE OF POSITIVE SURGICAL MARGINS ON PROSTATE CANCER-SPECIFIC MORTALITY (2011) (1)
- Clinical stage T2 prostate cancer treated with radical prostatectomy has similar outcome across its substages (2002) (1)
- 1023: The Role of Digital Rectal Examination in Prediction of Pathological Stage After Radical Prostatectomy in Contemporary Patients (2007) (1)
- Oncologic Outcomes of Total Length Gleason Pattern 4 on Biopsy in Men with Grade Group 2 Prostate Cancer (2022) (1)
- MP54-10 COMPARISON BETWEEN LIMITED AND EXTENDED LYMPH NODE DISSECTION FOR PROSTATE CANCER: RESULTS FROM A LARGE, CLINICALLY-INTEGRATED, RANDOMIZED TRIAL (2019) (1)
- MP89-18 ERECTILE FUNCTION CHANGES IN PATIENTS ENROLLED IN AN ACTIVE SURVEILLANCE PROGRAM FOR PROSTATE CANCER (2016) (1)
- 2023 ARE THE RIGHT MEN BEING SCREENED? TRENDS IN PSA SCREENING IN THE UNITED STATES (US) (2011) (1)
- HOW COMMON IS LATE RECURRENCE AFTER RADICAL PROSTATECTOMY (2008) (1)
- THE IMPACT OF CLINICAL CCP TESTING IN MEN WITH LOCALIZED PROSTATE CANCER FOR EXPANDING THE POPULATION OF MEN ELIGIBLE FOR ACTIVE SURVEILLANCE: PD28‐02 (2017) (1)
- 850 PRIMARY PROSTATE HIFU WITHOUT PRETREATMENT HORMONE THERAPY: BIOCHEMICAL SURVIVAL OF 763 PATIENTS TRACKED WITH THE @-REGISTRY (2009) (1)
- 139 THE RATE OF UPGRADING AND UPSTAGING ON IMMEDIATE REPEAT BIOPSY IN PATIENTS ELIGIBLE FOR ACTIVE SURVEILLANCE IS NOT RELATED TO EXTENT OF FIRST BIOPSY (2010) (1)
- Words of wisdom. Re: Comparative effectiveness of minimally invasive vs open radical prostatectomy. (2010) (1)
- MP78-03 ASSOCIATION BETWEEN NUMBER OF PROSTATE BIOPSIES AND PATIENT-REPORTED FUNCTIONAL OUTCOMES AFTER RADICAL PROSTATECTOMY: IMPLICATIONS FOR ACTIVE SURVEILLANCE PROTOCOLS (2015) (0)
- Reply by Authors. (2020) (0)
- 1460: Complications and Functional Outcomes of Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer (2004) (0)
- MP79-20 ASSESSING THE OPTIMAL TIMING OF POSTOPERATIVE TREATMENTS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH NODE-POSITIVE PROSTATE CANCER: RESULTS FROM A LARGE, MULTI-INSTITUTIONAL SERIES (2020) (0)
- MP48-05 COMPARATIVE OUTCOMES OF GLEASON GRADE 2 AND 3 PROSTATE CANCER ON INITIAL VERSUS CONFIRMATORY BIOPSY: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2019) (0)
- In Reply: Radical Retropubic Prostatectomy (1995) (0)
- Comparison of morbidity between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized trial (2020) (0)
- Surgery for progression after failed radiation therapy (2007) (0)
- EVALUATION OF A MULTIMODAL STRATEGY TO ACCELERATE DRUG EVALUATIONS IN EARLY STAGE METASTATIC PROSTATE CANCER: PD24‐11 (2017) (0)
- 017 Safety of Testosterone Therapy in Patients on Active Surveillance for Prostate Cancer (2017) (0)
- Salvage radical prostatectomy: Oncological outcomes from a large retrospective cohort study (2020) (0)
- Commentary RE: Radical Prostatectomy: Long-Term Results on Cancer Control, Survival and Trifecta (Freedom from PSA, Continence and Potency) Probabilities. (2020) (0)
- 2033 RESULT OF SECOND BIOPSY IS IMPORTANT FOR DECISION MAKING BEFORE ENTERING ACTIVE SURVEILLANCE PROTOCOL FOR LOW RISK PROSTATE CANCER (2010) (0)
- Role of radical prostatectomy in the treatment of high-risk prostate cancer (2008) (0)
- Baseline Testosterone Levels in Men with Clinically Localized High-Risk Prostate Cancer Treated with Radical Prostatectomy with or without Neoadjuvant Chemohormonal Therapy (Alliance). (2021) (0)
- Do concerns about more advanced pathological features increase the likelihood of neurovascular bundle resection in black men undergoing radical prostatectomy? (2004) (0)
- International : Active Surveillance ( PRIAS ) criteria for active surveillance of clinically low-risk prostate cancer patients (2017) (0)
- MP86-13 IMPACT OF TESTOSTERONE DEFICIENCY ON ERECTILE FUNCTION RECOVERY POST-RADICAL PROSTATECTOMY (2016) (0)
- 862: Comparative Evaluation of Free and Total Forms of Serum Human Glandular Kallikrein 2 and Prostrate Specific Antigen: Which Marker Should we Trust for Prediction of Locally Advanced and Recurrent Prostate Cancer? (2006) (0)
- COMPARATIVE ASSESSMENT OF FREE AND TOTAL FORMS OF SERUM HUMAN GLANDULAR KALLIKREIN 2 AND PROSTRATE SPECIFIC ANTIGEN FOR PREDICTION OF LOCALLY ADVANCED AND RECURRENT PROSTATE CANCER (2006) (0)
- PD4-11 INCREASING ELIGIBILITY FOR PROSTATE CANCER ACTIVE SURVEILLANCE: THE VALUE OF MULTIPARAMETRIC MRI FOR THE PREDICTION OF PATHOLOGICAL DOWNGRADING AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH BIOPSY-PROVEN GLEASON 3 + 4 PROSTATE CANCER (2014) (0)
- Role of PSMA PET-guided metastases-directed therapy in oligometastatic recurrent prostate cancer (2022) (0)
- Comprar Radical Prostatectomy. Surgical Perspectives | Eastham, J. | 9781461486923 | Springer (2013) (0)
- INCORPORATION OF HUMAN GLANDULAR KALLIKREIN 2 INTO A STANDARD NOMOGRAM TO PREDICT BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY. SIGNIFICANT ADVANTAGE FOR MEN WITH A PRE-TREATMENT PSA ≤ 10ng/ml (2008) (0)
- Words of wisdom. Re: Prostate cancer-specific survival following salvage radiotherapy versus observation in men with biochemical recurrence after radical prostatectomy. Trock BJ, Han M, Freedland SJ, Humphreys EB, DeWeese TL, Partin AW, Walsh PC. JAMA 2008;299:2760-9. (2009) (0)
- Wide excision radical prostatectomy: Indications and surgical technique (2007) (0)
- 727: Early Recurrences after Radical Prostatectomy for Prostate Cancer: Can we Identify Those Patients? (2007) (0)
- 263: Characteristics, Predictors of Recurrence and Survival of Patients with Seminal Vesicle Invasion after Radical Prostatectomy (2005) (0)
- 1011 COMPARISON OF STAGE MIGRATION PATTERNS BETWEEN NORTH AMERICA AND EUROPE: AN ANALYSIS OF 11350 MEN (2007) (0)
- 262 Assessing the optimal postoperative management of node positive prostate cancer patients: Results from a large, multi-institutional series (2014) (0)
- MP12-06 LONG-TERM RISK OF METASTATIC PROSTATE CANCER IN MEN WITH GRADE GROUP 2 MANAGED WITH ACTIVE SURVEILLANCE (2018) (0)
- 853: Bone Scan in Assessing Biochemical Failure After Radical Prostatectomy – Efficacy and Risk Factors for a Positive Scan (2004) (0)
- Patient CareEditorial Commentary (2015) (0)
- 579 SIZE OF TUMOR METASTASIS AND EXTRANODAL EXTENSION STRATIFY LYMPH NODE POSITIVE PROSTATE CANCER PATIENTS INTO PROGNOSTICALLY DIFFERENT RISK GROUPS (2010) (0)
- PD41-09 MOVING BEYOND PSA: IDENTIFYING THE OPTIMAL DIAGNOSTIC STRATEGY TO ASSESS PROSTATE CANCER RISK (2022) (0)
- PD2-04 SURGEON ADOPTION OF MINIMALLY INVASIVE RADICAL PROSTATECTOMY (2014) (0)
- Anatomic Radical Prostatectomy in the Management of Localized Prostate Cancer (2004) (0)
- 192 HIGH GRADE TUMOR VOLUME IS A POWERFUL MARKER IN PREDICTING BIOCHEMICAL RECURRENCE FOLLOWING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER (2012) (0)
- 1347 RISK OF HERNIA COMPLICATIONS AFTER MINIMALLY INVASIVE VERSUS OPEN RADICAL PROSTATECTOMY (2013) (0)
- PD44-01 WHEN SHOULD PROSTATE CANCER TUMOR SEQUENCING PROMPT CONSIDERATION FOR GERMLINE TESTING? (2021) (0)
- 285: The Impact of Socioeconomic Factors on Prostate Cancer Outcomes in a Large Series of African-American Patients (2007) (0)
- 398 SUBJECTIVITY IN MEASURING THE QUALITY OF PELVIC LYMPH NODE DISSECTION BY THE NUMBER OF LYMPH NODES REMOVED (2010) (0)
- 1000: Prediction and Natural History of Organ Confined Prostate Cancer after RP (2005) (0)
- 1405: Biopsy Gleason Upgrading by a Tertiary Referral Center is Associated with Increased Incidence of Lymph Node Involvement: Implications for Pelvic Lymphadenectomy Decision Models (2007) (0)
- 855: Radical Prostatectomy (RRP) in Men >70 Years Old: Effect of Age on Upgrading, Upstaging, and Accuracy of Preoperative Nomograms (2004) (0)
- 196 ACCURACY OF POST-RADIOTHERAPY BIOPSY PRIOR TO SALVAGE RADICAL PROSTATECTOMY (2012) (0)
- 1642 NERVE-SPARING IS ASSOCIATED WITH AN INCREASED RISK OF PROSTATE INCISION INTO TUMOR (PT2R1) DURING RADICAL PROSTATECTOMY (2012) (0)
- Application of active surveillance threshold to series of samples submitted for commercial testing. (2016) (0)
- 452 Updated postoperative nomogram incorporating the number of positive lymph nodes to predict disease recurrence following radical prostatectomy (2015) (0)
- 1147: Favorable Long-Term Outcomes in Patients with Seminal Vesicle Invasion or Lymph Node Invasion at Radical Prostatectomy (2007) (0)
- PD6-10 ADVERSE EVENTS AFTER RADICAL PROSTATECTOMY AND CURATIVE RADIOTHERAPY. POPULATION-BASED NATION-WIDE REGISTER STUDY (2015) (0)
- PD26-10 PREDICTING ERECTILE FUNCTION PRESERVATION AFTER PROSTATE CANCER TRIPLE THERAPY (2023) (0)
- The learning curve for surgical margins after open radical prostatectomy : implications for the use of margin status as an oncologic endpoint (2010) (0)
- 168 INCIDENCE AND IMPACT ON 15 YEAR SURVIVAL (DOC V DOD) OF GLEASON UPGRADING AFTER RADICAL PROSTATECTOMY (2012) (0)
- PD62-03 THE ASSOCIATION OF FAMILY HISTORY SUGGESTIVE OF HEREDITARY GERMLINE MUTATIONS WITH CLINICAL AND PATHOLOGICAL OUTCOMES IN PROSTATE CANCER PATIENTS ON ACTIVE SURVEILLANCE (2020) (0)
- MP45-08 PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5I) USE AFTER RADICAL PROSTATECTOMY (RP) IS NOT ASSOCIATED WITH INCREASED RISK OF BIOCHEMICAL RECURRENCE RISK (BCR) (2020) (0)
- DO PATIENTS WITH POSITIVE SURGICAL MARGINS AT RADICAL PROSTATECTOMY WITH FURTHER NEGATIVE RESECTED TISSUE BEHAVE LIKE PATIENTS WITH NEGATIVE MARGINS (2009) (0)
- Erratum: Evaluation of molecular forms of PSA and human kallikrein 2 in predicting biochemical failure following radical prostatectomy (International Journal of Cancer (2009) 125 (659-663) DOI:10.1002/ijc.23983) (2010) (0)
- RESEARCH — ERECTILE DYSFUNCTION Chronology of Erectile Function in Patients with Early Functional Erections Following (2010) (0)
- 049 Are we Improving Erectile Function Recovery after Radical Prostatectomy? Analysis of Patients Treated over the Last Decade (2019) (0)
- PD09-04 ESTIMATING THE HARMS AND BENEFITS OF PROSTATE CANCER SCREENING: COMPARING COMMON CLINICAL PRACTICE TO RECOMMENDED GOOD PRACTICE (2016) (0)
- 677 RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER: IMPACT OF THE DEFINITION AND SURGICAL APPROACH ON OUTCOME (2010) (0)
- 657 RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED, HIGH RISK PROSTATE CANCER: IMPACT OF THE DEFINITION AND SURGICAL APPROACH ON OUTCOME (2010) (0)
- 1487 PERSISTENT PROSTATE CANCER IN PATIENTS TREATED WITH PROSTATE RADIOTHERAPY WHO SUBSEQUENTLY UNDERGO RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER (2013) (0)
- ANALYZING THE OCCURRENCE OF PEYRONIE'S DISEASE AFTER RADICAL PROSTATECTOMY (2008) (0)
- Reliability and Validity of Prostate-Specific Antigen--Reply (2003) (0)
- MP27-04 ONCOLOGIC OUTCOMES IN MEN WITH ADVERSE PATHOLOGY AND BIOCHEMICAL PERSISTENCE AFTER RADICAL PROSTATECTOMY (2022) (0)
- THE INFLUENCE OF eIF4E ON ANGIOGENESIS IN PROSTATE TUMORS FROM AFRICAN-AMERICAN MEN (1999) (0)
- Highlights from the 20th International Prostate Cancer Update (2010) (0)
- Prostate Cancer: Surgical treatment of prostate cancer (2008) (0)
- Editorial: Neoadjuvant systemic therapies in bladder, kidney, and prostate cancers (2022) (0)
- MP54-06 STRIATED URETHRAL SPHINCTER FUNCTION FOLLOWING TRAINING IN MEN PRIOR TO RADICAL PROSTATECTOMY (2019) (0)
- The effect of the da Vinci® Vessel Sealer on robot-assisted laparoscopic prostatectomy complications. (2023) (0)
- MP38-05 OUTCOMES OF GRADE GROUP 2 AND 3 PROSTATE CANCER ON INITIAL VERSUS CONFIRMATORY BIOPSY: IMPLICATIONS FOR ACTIVE SURVEILLANCE (2022) (0)
- 128 POSITIVE SURGICAL MARGINS INCREASE THE RISK OF BIOCHEMICAL RECURRENCE INDEPENDENTLY FROM PATHOLOGICAL STAGE OR GRADE (2007) (0)
- MP57-07 IMPACT OF THE MINIMALLY INVASIVE APPROACH ON MORBIDITY OF SALVAGE RADICAL PROSTATECTOMY (2022) (0)
- 342 COMPARISON OF THE INCIDENCE OF SECONDARY CANCERS AFTER IMRT, BRACHYTHERAPY AND SURGERY FOR THE TREATMENT OF PROSTATE CANCER (2012) (0)
- THE OFFICIAL NEWSMAGAZINE OF THE AMERICAN UROLOGICAL ASSOCIATION AND CONFEDERACIÓN AMERICANA DE UROLOGÍA (2021) (0)
- 265: A Constitutively Activated Mutant form of Propsa that Manifests Catalytic Action Increases Cell Invasion in Vitro and Frequency of Pulmonary Metastases in vivo in a Subcutaneous Mouse Xenograft Model (2007) (0)
- A study of endorectal MRI and MRSI of the prostate as predictive biomarkers of biochemical relapse after radical prostatectomy (2010) (0)
- PRE-DIAGNOSTIC PROSTATE SPECIFIC ANTIGEN DYNAMICS DO NOT IMPROVE AN OUTCOME PREDICTION MODEL CONTAINING PROSTATE SPECIFIC ANTIGEN LEVELS ALONE IN PATIENTS WITH CLINICALLY LOCALIZED PROSTATE CANCER TREATED CONSERVATIVELY OR WITH EARLY HORMONAL THERAPY (2008) (0)
- Evolution of Radical Prostatectomy as It Pertains to Nerve-Sparing (2009) (0)
- MP45-01 PREDICTING PROGRESSION IN PATIENTS FOLLOWED WITH ACTIVE SURVEILLANCE FOR LOW-RISK PROSTATE CANCER (2014) (0)
- Value of PSA measured in middle age in predicting diagnosis of advanced prostate cancer in an unscreened population (2007) (0)
- MP67-13 COMPARISON OF MORBIDITY BETWEEN LIMITED AND EXTENDED PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER: RESULTS FROM A LARGE, CLINICALLY-INTEGRATED, RANDOMIZED TRIAL (2020) (0)
- Reply by Authors. (2021) (0)
- 119 NO DIFFERENCES IN BIOCHEMICAL RECURRENCE BETWEEN NO AND NX PATIENTS SUBJECTED TO RADICAL PROSTATECTOMY: A MATCHED ANALYSES ON 5977 PATIENTS (2007) (0)
- 474 ASSOCIATION OF THE NUMBER OF LYMPH NODES (LN) REMOVED AT RADICAL PROSTATECTOMY WITH ALL-CAUSE (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) (2011) (0)
- Metabolic signature of prostate cancer as detected with proton magnetic resonance spectroscopic imaging and 18 F-fluorodeoxyglucose-positron emission tomography (2012) (0)
- TREATMENT OF PROSTATE CANCER: SURGERY (2011) (0)
- 741: A Very Small Proportion of Patients with Localized Prostate Cancer Shed Circulating Prostate Cells Using Real-Time RT-PCR for KLK2 and KLK3 Mrnas, which Enables Reliable CPC Detection in Metastatic Disease (2007) (0)
- 453 THE ASSOCIATION OF GENITOURINARY CANCERS WITH BRCA CARRIER STATUS IN A CLINICALLY TESTED COHORT FROM A SINGLE INSTITUTION (2013) (0)
- ClariCore™ Optical Biopsy System for Prostate Cancer Diagnosis: Preliminary Results from a Multicenter Clinical Trial (2017) (0)
- Deep Imaging Beyond the Diffusion Approximation: Using Linear and Nonlinear Optical Methods (2017) (0)
- DEFINING THE INDEX LESION FOR SALVAGE PARTIAL GLAND ABLATION AFTER RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: MP70‐05 (2017) (0)
- Long-term Health-related Quality of Life in Patients on Active Surveillance for Prostate Cancer: A Systematic Review. (2022) (0)
- 652 UNIFORM ANATOMIC TEMPLATE FOR PELVIC LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY: COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PROCEDURES (2011) (0)
- 1318: Anatomy and Preservation of Accessory Pudendal Arteries in Laparoscopic Radical Prostatectomy (2006) (0)
- The 11th American Urological Association and the Japanese Urological Association International Affiliate Society Meeting (2016) (0)
- Prostate Cancer: Localized: Surgical Therapy IMP40-12 LONG-TERM ONCOLOGICAL OUTCOMES OF SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT/PERSISTENT PROSTATE CANCER AFTER RADIATION THERAPY. (2016) (0)
- Genitourinary tumors (2022) (0)
- Long-term oncologic outcomes of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localized, high-risk prostate cancer. (2014) (0)
- 673: Utility of Resection of Additional Peri-Prostatic Tissue in Patients Undergoing Radical Prostatectomy (2006) (0)
- LONG-TERM FOLLOWUP OF NEOADJUVANT HORMONE THERAPY BEFORE RADICAL PROSTATECTOMY: MEMORIAL SLOAN-KETTERING CANCER CENTER RESULTS (2009) (0)
- 465: Proposal for a Correction of the AJCC Staging System for Prostate Cancer Patients Treated with Radical Prostatectomy (2007) (0)
- Spontaneous drainage of an appendiceal abscess into an orthotopic neobladder. (1996) (0)
- Words of wisdom. Re: Radical prostatectomy versus observation for localized prostate cancer. (2013) (0)
- 1874 A WEB-BASED SYSTEM FOR ASSESSING ERECTILE AND URINARY FUNCTION IN PATIENTS AFTER RADICAL PROSTATECTOMY (2010) (0)
- 1602: Time from Prostate Biopsy to Radical Prostatectomy does Not Impact Surgical Difficulty or Efficacy (2006) (0)
- 195. Outcomes After Salvage Radical Prostatectomy (2009) (0)
- Comprehensive comparison of health-related quality of life after radical prostatectomy, high- dose intensity modulated radiotherapy and intraoperative conformal brachytherapy for localized prostate cancer (2002) (0)
- 1879: Larger Prostate Glands are Associated with a Lower Rate of Upgrading between Biopsy and Radical Prostatectomy (2007) (0)
- EXTENDED PELVIC LYMPH NODE DISSECTION AT ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (2011) (0)
- 1490: Association of Ethnicity, PSA Velocity and PSA Density Among Patients Found to have Cancer on Repeat Prostate Biopsy (2006) (0)
- 1316: Determinants of Success of Bilateral Cavernous Nerve Interposition Grafting During Radical Retropubic Prostatectomy (2006) (0)
- 570 PELVIC LYMPH NODE DISSECTION FOR PROSTATE CANCER IN PATIENTS WITH AN ELEVATED RISK OF LYMPH NODE INVASION IN A CONCURRENT CONTEMPORARY SERIES: COMPARISON OF OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED APPROACHES. (2011) (0)
- Patient-reported financial toxicity following management of localized prostate cancer. (2021) (0)
- CORRELATION OF BIOCHEMICAL EVENTS AND CLINICAL FAILURE FOLLOWING HIGH INTENSITY FOCUSED ULTRASOUND OF THE PROSTATE: THE STUTTGART DEFINTION (2009) (0)
- Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence (2021) (0)
- 1876: A Single PSA Measurement in Middle Age Predicts Diagnosis of Advanced Prostate Cancer Up to 25 Years Later in an Unscreened Population (2007) (0)
- OP2-04 DIFFUSION OF MINIMALLY INVASIVE RADICAL PROSTATECTOMY: THE PUBLIC CONSEQUENCE OF AN UNTESTED TREATMENT (2014) (0)
- 1072 Functional outcomes in contemporary high-risk prostate cancer treated by open or minimally invasive radical prostatectomy between 2003 and 2012 (2014) (0)
- 943 ARE RESULTS OF FOCAL THERAPY FOR LOCALIZED PROSTATE CANCER ONLY DUE TO TUMOUR ABLATION? CRITICAL ANALYSIS OF DEFINITIONS FOR SUCCESS APPLIED IN A COHORT OF ACTIVE SURVEILLANCE PATIENTS (2010) (0)
- 1598: The Significance of the Extent of Capsular Invasion in Localized Prostate Cancer (2006) (0)
- 508 A COMPARISON OF BIOCHEMICAL RECURRENCE RATES OF OPEN AND ROBOTIC PROSTATECTOMY AT A LARGE TERTIARY CARE CENTER (2012) (0)
- PD27-09 MANAGEMENT OF RECURRENT PROSTATE CANCER AFTER RADIOTHERAPY: LONG-TERM RESULTS FROM CALGB 9687, A CONTEMPORARY PROSPECTIVE MULTI-INSTITUTIONAL SALVAGE PROSTATECTOMY SERIES (2014) (0)
- Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer. (2021) (0)
- 1872 IMPACT OF PELVIMETRY ON RECOVERY OF POTENCY AND CONTINENCE AND COMPLICATIONS AFTER RADICAL PROSTECTOMY (2010) (0)
- Impact of Zone of Origin in Anterior Dominant Prostate Cancer: Long-Term Biochemical Recurrence-Free Survival in an Anatomically Well-Characterized Cohort. (2022) (0)
- Management of recurrent prostate cancer after radiotherapy: long-term results from CALGB 9687 (Alliance), a prospective multi-institutional salvage prostatectomy series (2018) (0)
- 1629 PREOPERATIVE TOTAL TESTOSTERONE LEVELS DO NOT PREDICT PATHOLOGIC STAGE IN CLINICALLY LOCALIZED PROSTATE CANCER (2011) (0)
- 1143: Positive Surgical Margins Increase the Risk of Biochemical Recurrence Independently from Pathological Stage or Grade (2007) (0)
- Seminar article Critical elements in fellowship training (2009) (0)
- MORPHOLOGIC CHARACTERISTICS AT THE TIME OF PROSTATECTOMY IN LYMPH NODE POSITIVE PATIENTS (2009) (0)
- Faculty Opinions recommendation of Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial. (2020) (0)
- 914 LARGER PROSTATE GLANDS ARE ASSOCIATED WITH A LOWER RATE OF UPGRADING BETWEEN BIOPSY AND RADICAL PROSTATECTOMY (2007) (0)
- Correction: Estimating patient health in prostate cancer treatment counseling (2022) (0)
- 027 Is There a Relationship Between Phosphodiesterase Type 5 Inhibitors (PDE5i) and Prostate Cancer Biochemical Recurrence (2017) (0)
- 639 EVALUATION OF CANCER CONTROL AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY (2009) (0)
- MP15-07 ANALYSIS OF PERIOPERATIVE COMPLICATIONS IN PATIENTS WITH PROSTATE CANCER BASED ON EXTENSION OF PELVIC LYMPH NODE DISSECTION (2021) (0)
- 904 DIAGNOSIS AND TREATMENT OF PROSTATE CANCER WITH RADICAL PROSTATECTOMY AT AN EARLIER AGE DOES NOT AFFECT THE PATHOLOGICAL STAGE (2007) (0)
- Author Reply. (2016) (0)
- The knowledge and practices of urologists in the United States (US) about standardization of PSA assays. (2011) (0)
- DOES THE NUMBER OF GLEASON 6 POSITIVE CORES ON PROSTATE BIOPSY PREDICT ADVERSE PATHOLOGY AT RADICAL PROSTATECTOMY IN PATIENTS WHO ARE CANDIDATES FOR ACTIVE SURVEILLANCE?: PD61‐10 (2017) (0)
- 388: Clinical T3 Prostate Cancer Treated with Radical Prostatectomy: Pathological and long-term Outcomes (2007) (0)
- What is the probability of a positive bone scan (+BS) in patients with a rising PSA after radical prostatectomy (RP): A new nomogram. (2004) (0)
- Late Toxicity following High Dose Post-prostatectomy Salvage Radiation Therapy (2011) (0)
- 719 Oncological outcomes according to different high-risk prostate cancer definitions (2014) (0)
- 715 Can transrectal needle biopsy be optimized to detect nearly all prostate cancer with volume ≥0.5 cc? A three-dimensional analysis (2013) (0)
- 911 PREDICTION OF OUTCOME AFTER RADICAL PROSTATECTOMY USING A TISSUE MICROARRAY OF 947 PRIMARY PROSTATE CANCERS AND IMMUNOHISTOCHEMICAL DETECTION OF CYSTEINE-RICH SECRETORY PROTEIN 3 (CRISP-3) AND BETA-MICROSEMINOPROTEIN (MSP) (2007) (0)
- 120 CLINICIANS CAN ACCURATELY SELECT PATIENTS IN WHOM LYMPHADENECTOMY MAY BE SAFELY OMITTED AT RADICAL PROSTATECTOMY (2007) (0)
- PREDICTING RISK OF PROSTATE CANCER-SPECIFIC MORTALITY BASED ON CLINICOPATHOLOGIC FEATURES AT RADICAL PROSTATECTOMY (2008) (0)
- 135 DURABLE CANCER CONTROL IN HIGH RISK PROSTATE CANCER PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2007) (0)
- Moving beyond PSA: Identifying the optimal diagnostic strategy to assess prostate cancer risk (2022) (0)
- Reply to D.A. Hamstra et al and A.P. Sandhu (2010) (0)
- 272: Cancer Characteristics and Cancer Control in Men with PSA of 4 Ngzml or Less Treated with Radical Prostatectomy (RP) (2005) (0)
- Faculty Opinions recommendation of Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study. (2020) (0)
- Corrigendum to “New Clinical Tools for Urologists: Treatment of Bone Loss” [Eur Urol Suppl 2006;5:877–879] (2007) (0)
- 1949 LYMPH NODE YIELD USING THE STANDARD LYMPH NODE DISSECTION DURING RADICAL PROSTATECTOMY (2010) (0)
- Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence. (2022) (0)
- MP74-10 VARIATION OF SERUM PROSTATE-SPECIFIC ANTIGEN LEVELS FOR MEN WITH PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE (2014) (0)
- 1065 PREDICTORS OF ONCOLOGIC OUTCOMES AFTER SALVAGE RADICAL PROSTATECTOMY FOR RADIO-RECURRENT PROSTATE CANCER: A MULTI-INSTITUTIONAL COLLABORATION (2010) (0)
- 1030 EARLY RECURRENCES AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER: CAN WE IDENTIFY THOSE PATIENTS? (2007) (0)
- Localizing sites of disease in patients with rising PSA up to 1 ng/mL following prostatectomy: how much information can conventional imaging provide? (2016) (0)
- 1031: Comparison of Stage Migration Patterns Between North America and Europe: An Analysis of 11350 Men (2007) (0)
- 564: Clinicians Can Accurately Select Patients in Whom Lymphadenectomy may be Safely Omitted at Radical Prostatectomy (2007) (0)
- 524 IMPACT OF SURGICAL MARGIN LENGTH, NUMBER AND GLEASON ON BIOCHEMICAL RECURRENCE FOR MEN UNDERGOING RADICAL PROSTATECTOMY (2007) (0)
- Selecting Patients with Favourable-Risk, GG2 Prostate Cancer for Active Surveillance: Does MRI Have a Role? (2020) (0)
- 1057 THE IMPACT OF PROSTATE CANCER NATURAL HISTORY ON FOCAL ABLATION RESULTS (2010) (0)
- PD55-05 NEGATIVE MRI CANNOT BE USED TO AVOID BIOPSY IN ACTIVE SURVEILLANCE FOR PROSTATE CANCER (2019) (0)
- MP69-09 TOPOGRAPHY OF RECURRENT PROSTATE CANCER BASED ON SALVAGE RADICAL PROSTATECTOMY TUMOR MAPS (2016) (0)
- Relative contribution of androgen deprivation therapy in combination with adjuvant radiotherapy for node-positive prostate cancer (2021) (0)
- Striated urethral sphincter function following training in men prior to radical prostatectomy (2020) (0)
- 967: The Anatomic and Pathologic Characteristics of Irradiated Prostate Cancers May Influence the Oncologic Efficacy of Salvage Therapies (2006) (0)
- 006 Safety of Testosterone Therapy in Patients on Active Surveillance for Prostate Cancer (2017) (0)
- MP70-21 ASSESSING THE OPTIMAL POST-OPERATIVE MANAGEMENT OF NODE POSITIVE PROSTATE CANCER PATIENTS:RESULTS FROM MULTI-INSTITUTIONAL SERIES (2014) (0)
- Prostate Cancer: Epidemiology & Natural History IIMP09-19 CLINICAL FINDINGS AND TREATMENT OUTCOMES IN PATIENTS WITH EXTRAPROSTATIC EXTENSION IDENTIFIED ON PROSTATE BIOPSY (2016) (0)
- The occurrence of urologic injuries in patients with gunshot wounds to the spine. (1992) (0)
- 471: Biopsy Gleason 8-10 Prostate Cancer: Incidence of Downgrading and Outcome (2005) (0)
- PREDICTING EXTENSIVE DISEASE AMONG POTENTIAL CANDIDATES FOR HEMI‐ABLATIVE FOCAL THERAPY FOR PROSTATE CANCER: MP70‐12 (2017) (0)
- MP50-01 SURVIVAL ANALYSIS OF PATIENTS WITH NODE POSITIVE PROSTATE CANCER AFTER RADICAL PROSTATECTOMY COMPARING OBSERVATION VS. ADJUVANT ANDROGEN DEPRIVATION THERAPY ALONE VS. ADJUVANT ANDROGEN DEPRIVATION PLUS EXTERNAL BEAM RADIATION THERAPY. (2016) (0)
- 368 SEMINAL VESICLE INVOLVEMENT AT SALVAGE PROSTATECTOMY (2012) (0)
- 807: The Learning Curve for Robotic-Assisted Radical Prostatectomy: A Multiinstitutional Experience of Laparoscopic and Oncologic Trained Urologists (2007) (0)
- MP36-06 VALIDATION OF AUA BEST PRACTICE GUIDELINES FOR PROSTATE BIOPSY INFECTIOUS COMPLICATIONS AND REDUCING VARIABILITY AND DURATION OF ANTIMICROBIAL UTILIZATION: QUALITY IMPROVEMENT INITIATIVE (2016) (0)
- MP13-06 MULTICENTER CLINICAL TRIAL OF REAL-TIME PROSTATE CANCER DIAGNOSIS USING OPTICAL SPECTROSCOPY GUIDED PROSTATE BIOPSY (2019) (0)
- A non-invasive urine exosome gene expression assay (ExoIntelliScore Prostate) to predict pathologic stage and grade in the prostatectomy specimen. (2016) (0)
- EVALUATION OF CANCER CONTROL AFTER OPEN AND LAPAROSCOPIC RADICAL PROSTATECTOMY: 10-YEAR EXPERIENCE (2009) (0)
- Evaluation of a multimodal strategy to accelerate drug evaluations in early-stage metastatic prostate cancer. (2017) (0)
- MP19-19 PREDICTING PROFICIENCY DURING ROBOTIC PROSTATECTOMY OF UROLOGY TRAINEES USING A NOVEL, SYSTEMIC SURGICAL TRAINING PROGRAM (2022) (0)
- Deep Imaging of Prostate Cancer Using Diffusion Reconstruction of Banana Paths with Near Infrared Prostatoscope Analyzer (2017) (0)
- MP12-16 THE DURATION OF ANTIBIOTICS PROPHYLAXIS AT THE TIME OF CATHETER REMOVAL AFTER RADICAL PROSTATECTOMY (2020) (0)
- 1024 CLINICAL T3 PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY: PATHOLOGICAL AND LONG-TERM OUTCOMES (2007) (0)
- 1950 IMPACT OF EXTENDED PELVIC LYMPH NODE DISSECTION ON NOMOGRAM PREDICTION OF LYMPH NODE INVOLVEMENT DURING RADICAL PROSTATECTOMY (2010) (0)
- 1002: The Impact of Time from Biopsy to Surgery on Biochemical Recurrence Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2005) (0)
- Decreasing postoperative opioid prescriptions in ambulatory extended recovery patients. (2019) (0)
- 637: Clinical Significance of Prostate Cancers Detected by Extended Biopsy (2004) (0)
- Assessing Quality and Safety of an Advanced Practice Provider-led Active Surveillance Clinic for Men with Prostate Cancer. (2021) (0)
- Review article Radical prostatectomy: Positive surgical margins matter (2013) (0)
- Tissue segmentation improves prostate cancer detection with artificial neural networks analysis of 1 H MRSI (2009) (0)
- 390: Durable Cancer Control in High Risk Prostate Cancer Patients Treated with Radical Prostatectomy (2007) (0)
- 756 A RISK ADJUSTED FOLLOW UP SCHEME AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER (2007) (0)
- Reply by Authors. (2021) (0)
- 934 PROSTATE SIZE AND RISK OF CAPSULAR INCISION AT RADICAL PROSTATECTOMY (2010) (0)
- 343 ANDROGEN DEPRIVATION AND THROMBOEMBOLIC EVENTS IN MEN WITH PROSTATE CANCER (2011) (0)
- Characterization of Symptoms after Radical Prostatectomy and Their Relation to Postoperative Complications (2021) (0)
- Defining the index lesion for salvage partial gland ablation after radiation therapy for localized prostate cancer. (2017) (0)
- MP11-12 ARE WE IMPROVING ERECTILE FUNCTION RECOVERY AFTER RADICAL PROSTATECTOMY? (2018) (0)
- 845: Extended Biopsy Schemes are Associated with Similar Pathological Characteristics but Lower Biochemical Recurrence than Sextant Biopsy (2007) (0)
- 1139: Risk Adjusted Analysis of Positive Surgical Margins Following Laparoscopic and Retropubic Radical Prostatectomy (2006) (0)
- 992 15-YEAR ALL-CAUSE MORTALITY (ACM) AND PROSTATE CANCER-SPECIFIC MORTALITY (PCSM) AMONG MEN WITH BIOPSY GLEASON 2-6 CANCERS (2012) (0)
- MP77-11 THE ONCOLOGIC RISK OF MRI-TARGETED AND SYSTEMATIC CORES IN PATIENTS TREATED WITH RADICAL PROSTATECTOMY (2023) (0)
- Letters to the Editor/Errata Re: Location, Extent and Number of Positive Surgical Margins do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy (2011) (0)
- 1750: PSA Velocity does not aid long-term Prediction of Cancer in a large Representative Population of middle-aged men with no History of Prior PSA-Testing (2007) (0)
- 651: Long-Term Risk of Metastatic Progression of Prostate Cancer Following Radical Prostatectomy (2006) (0)
- Incidence of periprostatic white adipose tissue inflammation in men with prostate cancer. (2017) (0)
- MP6-16 GERMLINE VARIANTS WITHIN THE PTEN/PI3K AXIS AND ASSOCIATION WITH CASTRATE RESISTANT PROSTATE CANCER AND PROSTATE CANCER SPECIFIC MORTALITY (2015) (0)
- Mp78-18 the Economic Impact of Robotic and Open Radical Prostatectomy on Patients and Their Families (2014) (0)
- 729: A Risk Adjusted Follow Up Scheme after Radical Prostatectomy for Prostate Cancer (2007) (0)
- Total androgen-receptor gene expression inhibitor therapy (TARGET): A phase II trial of neoadjuvant SAHA (S) followed prostatectomy for patients (pts) with high-risk prostate cancer (pc). (2010) (0)
- MP52-03 CORRELATION OF THE TYPE OF PELVIC NODE DISSECTION DURING RADICAL PROSTATECTOMY TO THE PATTERN OF NODAL RECURRENCE AT SALVAGE LYMPHADENECTOMY FOR PROSTATE CANCER (2018) (0)
- 407 THE RELATIONSHIP BETWEEN THE LINEAR EXTENT OF POSITIVE SURGICAL MARGIN OR INTIMATE CAPSULAR CONTACT IN PROSTATECTOMY SPECIMENS AND PROGRESSION (2010) (0)
- Surgical center for ambulatory extended recovery: 30-day follow-up report of minimally invasive radical prostatectomy. (2017) (0)
- 1873 PREDICTORS OF BLADDER NECK CONTRACTURE FOLLOWING RADICAL PROSTATECTOMY (2010) (0)
- Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer (2013) (0)
- Comparison of erectile function recovery between limited and extended pelvic lymph node dissection for prostate cancer: Results from a large, clinically-integrated, randomized trial (2020) (0)
- POD-4.03: Complications of Radical Prostatectomy: Analysis of Predictors (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With James Andrew Eastham?
James Andrew Eastham is affiliated with the following schools:
